CED News


December 17, 2007

Optimal Technologies to Relocate Corporate HQ to Raleigh

SC Launch! Receives $650,000 Grant from Progress Energy

Targacept Receives $6M Payment from GSK, Begins Phase I Trial of Neuropathic Pain Treatment

SCYNEXIS Earns Milestone Payment from Collaborator Merial

Chimerix Initiates Trial for Smallpox Infection Treatment

Inlet Technologies Raises $3M from Investors

Cempra Pharmaceuticals Raises Additional $10M

Arcapita Co-Leads $15.5M Investment in RFID Company

Optimal Technologies to Relocate Corporate HQ to Raleigh

SC Launch! Receives $650,000 Grant from Progress Energy

Targacept Receives $6M Payment from GSK, Begins Phase I Trial of Neuropathic Pain Treatment

SCYNEXIS Earns Milestone Payment from Collaborator Merial

Chimerix Initiates Trial for Smallpox Infection Treatment

Inlet Technologies Raises $3M from Investors

Cempra Pharmaceuticals Raises Additional $10M

Arcapita Co-Leads $15.5M Investment in RFID Company

December 10, 2007

Novartis, MorphoSys Enter into $1B Development Agreement

FDA Clears CONFIDANT for OTC Sales of Mobile Disease Management System

Targacept Begins Phase I Trials for Neuropathic Pain Treatment

Serenex Begins Second Phase I Trials for Cancer Treatment

Metastatix Launches Phase I Clinical Trial of Potential Cancer Drug

IBM Sets $1B Buy Back Goal

RTI Lands $2M Grant from the U.S. Dept. of Energy for Biofuels Project

Red Hat Earns 4th Consecutive “Most Valuable Software Vendor” Label in 2007 CIO Insight Study

Arsenal Digital to be Acquired by IBM

CEI Awarded SBIR Grant from U.S. Army

PHB Gets $250K Loan from NC Biotechnology Center

InnerOptic Slated to Raise $370K in Venture Funding

Arcapita Leads $33M Round of Funding for CardioMEMS

Novartis, MorphoSys Enter into $1B Development Agreement

FDA Clears CONFIDANT for OTC Sales of Mobile Disease Management System

Targacept Begins Phase I Trials for Neuropathic Pain Treatment

Serenex Begins Second Phase I Trials for Cancer Treatment

Metastatix Launches Phase I Clinical Trial of Potential Cancer Drug

IBM Sets $1B Buy Back Goal

RTI Lands $2M Grant from the U.S. Dept. of Energy for Biofuels Project

Red Hat Earns 4th Consecutive “Most Valuable Software Vendor” Label in 2007 CIO Insight Study

Arsenal Digital to be Acquired by IBM

CEI Awarded SBIR Grant from U.S. Army

PHB Gets $250K Loan from NC Biotechnology Center

InnerOptic Slated to Raise $370K in Venture Funding

Arcapita Leads $33M Round of Funding for CardioMEMS

December 3, 2007

FDA, Duke Collaborate on Clinical Trials Modernization

Duke, NCSU Scientists Garner Photonics Consortium Grants

NCSU Virtual Computing Lab Accepts $2.4 Million Gift from Intel

Inspire Launches Phase III Clinical Trials for Nasal Spray

Southern Capitol Ventures Participates in $4 Million Series B Round for Baltimore Company

Oriel Therapeutics Raises $26.5 Million in VC Funding

BluePhoenix Raises $35 Million in Private Stock Placement

FDA, Duke Collaborate on Clinical Trials Modernization

Duke, NCSU Scientists Garner Photonics Consortium Grants

NCSU Virtual Computing Lab Accepts $2.4 Million Gift from Intel

Inspire Launches Phase III Clinical Trials for Nasal Spray

Southern Capitol Ventures Participates in $4 Million Series B Round for Baltimore Company

Oriel Therapeutics Raises $26.5 Million in VC Funding

BluePhoenix Raises $35 Million in Private Stock Placement

November 26, 2007

Outstanding Achievement Award

PTRP Gains New President

BioMarck Pharmaceuticals Awarded Patent Protection

Argos Therapeutics Enters Into Licensing Agreement with J&J Subsidiary

Biogen Idec Partners with Swiss Company on Development of Alzheimer’s Treatment

Red Hat Extends Collaboration with Hyperic on Common Systems Management Technology

Southern Capitol Ventures Participates in $4 Million Series B Round for Baltimore Company

Oriel Therapeutics Raises $26.5 Million in VC Funding

BluePhoenix Raises $35 Million in Private Stock Placement

GSK Acquires NJ Pharma Company for $1.65 Billion

Outstanding Achievement Award

PTRP Gains New President

BioMarck Pharmaceuticals Awarded Patent Protection

Argos Therapeutics Enters Into Licensing Agreement with J&J Subsidiary

Biogen Idec Partners with Swiss Company on Development of Alzheimer’s Treatment

Red Hat Extends Collaboration with Hyperic on Common Systems Management Technology

Southern Capitol Ventures Participates in $4 Million Series B Round for Baltimore Company

Oriel Therapeutics Raises $26.5 Million in VC Funding

BluePhoenix Raises $35 Million in Private Stock Placement

GSK Acquires NJ Pharma Company for $1.65 Billion

November 19, 2007

Smith Anderson's Mason Participates in UNC Kenan-Flagler Undergraduate Business Symposium

NCSU Teams Up with Xerox in Professional and Innovation Management Course Development

RTI International Awarded $6.8 Million for Genetics Research

Centice Closes on $11.3 Million

Firethorn Acquired by Qualcomm for $210 Million

RFMD Acquires Sirenza Microdevices for $900 Million

Smith Anderson's Mason Participates in UNC Kenan-Flagler Undergraduate Business Symposium

NCSU Teams Up with Xerox in Professional and Innovation Management Course Development

RTI International Awarded $6.8 Million for Genetics Research

Centice Closes on $11.3 Million

Firethorn Acquired by Qualcomm for $210 Million

RFMD Acquires Sirenza Microdevices for $900 Million

November 12, 2007

NC Biotechnology Center Grants $100K to Establish State’s First Center of Innovation

BDSI Files New Drug Application for BEMA Fentanyl

Addrenex, Sciele Begin Phase III Clinical Trials for ADHD Treatment

Metastatix Receives FDA Approval to Start Phase I Clinical Trial on Tumor Treatment

Hamner Institutes Receives $970,000 Grant

NCSU Centennial Campus Ranked No. 1 Research Science Park

NC Ranks No. 1 in U.S. for Business Relocation and Expansion

EMC2 Acquires Texas Software Company

Targacept Approves $2 Million License Agreement with AstraZeneca

Chrysalis Ventures Invests $2.5 Million in VoIP Company

Piedmont Pharmaceuticals Raises $8.5 Million

LED Lighting Fixtures Raises $16.5 Million

Tranzyme Closes $20 Million Round of Funding

Updata Partners Participates in $28 Million Investment in VA HHS Software Company

Chelsea Therapeutics Raises $48.9 Million in Private Placement Deal

NC Biotechnology Center Grants $100K to Establish State’s First Center of Innovation

BDSI Files New Drug Application for BEMA Fentanyl

Addrenex, Sciele Begin Phase III Clinical Trials for ADHD Treatment

Metastatix Receives FDA Approval to Start Phase I Clinical Trial on Tumor Treatment

Hamner Institutes Receives $970,000 Grant

NCSU Centennial Campus Ranked No. 1 Research Science Park

NC Ranks No. 1 in U.S. for Business Relocation and Expansion

EMC2 Acquires Texas Software Company

Targacept Approves $2 Million License Agreement with AstraZeneca

Chrysalis Ventures Invests $2.5 Million in VoIP Company

Piedmont Pharmaceuticals Raises $8.5 Million

LED Lighting Fixtures Raises $16.5 Million

Tranzyme Closes $20 Million Round of Funding

Updata Partners Participates in $28 Million Investment in VA HHS Software Company

Chelsea Therapeutics Raises $48.9 Million in Private Placement Deal

October 30, 2007

Targacept Plans to Advance TC-5214 as Augmentation Therapy for Depression

Lab Corp Partners with New Jersey Firm in Genomics Exploration

BTEC Awarded $455,000 FDA Grant

WUNC Entrepreneurs Challenge Generates over $11,000

Quintiles Latin America Acquires Bio-Trials

PhaseBio Lands Additional $5.4 Million in Funding

Vitrue Closes on $10 Million Series B Funding

Cisco Acquires WiMax Wireless Technology

Targacept Plans to Advance TC-5214 as Augmentation Therapy for Depression

Lab Corp Partners with New Jersey Firm in Genomics Exploration

BTEC Awarded $455,000 FDA Grant

WUNC Entrepreneurs Challenge Generates over $11,000

Quintiles Latin America Acquires Bio-Trials

PhaseBio Lands Additional $5.4 Million in Funding

Vitrue Closes on $10 Million Series B Funding

Cisco Acquires WiMax Wireless Technology

October 23, 2007

eTrials Partners with TransPerfect on Translation Services

Entegrion Awarded $2 Million for Development of Trauma Treatment

Local Universities Receive Federal Grants for Genomics Research

UNCW Earns Ranking on Princeton Review’s “Best” List

Biolex Therapeutics Releases Phase 2a Clinical Results for Hepatitis C Treatment

Oriel Therapeutics Raises Third Round of Funding

Aurora Funds Participates in $20 Million Investment in GA-based Pharma Company

Tengion Raises $33 Million in Third Round

Motricity to Acquire InfoSpace Mobile Services Division for $135 Million

Arysta LifeScience Sold to Permira Advisers for $2.2 Billion

eTrials Partners with TransPerfect on Translation Services

Entegrion Awarded $2 Million for Development of Trauma Treatment

Local Universities Receive Federal Grants for Genomics Research

UNCW Earns Ranking on Princeton Review’s “Best” List

Biolex Therapeutics Releases Phase 2a Clinical Results for Hepatitis C Treatment

Oriel Therapeutics Raises Third Round of Funding

Aurora Funds Participates in $20 Million Investment in GA-based Pharma Company

Tengion Raises $33 Million in Third Round

Motricity to Acquire InfoSpace Mobile Services Division for $135 Million

Arysta LifeScience Sold to Permira Advisers for $2.2 Billion

October 17, 2007

Arbor Pharmaceuticals to Partner with Campbell University on Pediatric Treatment

eTrials Partners with TransPerfect on Translation Services

Entegrion Awarded $2 Million for Development of Trauma Treatment

Local Universities Receive Federal Grants for Genomics Research

INC Research to Add 1,100 Jobs in Raleigh

Advanced Solutions Acquires Cadre Systems

Align Pharmaceuticals Acquired by Cyclacel

DARA Biosciences Acquires Point Therapeutics in Reverse Merger

Oriel Therapeutics Raises Third Round of Funding

Frontier Capital Invests $6.5 Million in M3TG

Aurora Funds Participates in $20 Million Investment in GA-based Pharma Company

Tengion Raises $33 Million in Third Round

Motricity to Acquire InfoSpace Mobile Services Division for $135 Million

Arbor Pharmaceuticals to Partner with Campbell University on Pediatric Treatment

eTrials Partners with TransPerfect on Translation Services

Entegrion Awarded $2 Million for Development of Trauma Treatment

Local Universities Receive Federal Grants for Genomics Research

INC Research to Add 1,100 Jobs in Raleigh

Advanced Solutions Acquires Cadre Systems

Align Pharmaceuticals Acquired by Cyclacel

DARA Biosciences Acquires Point Therapeutics in Reverse Merger

Oriel Therapeutics Raises Third Round of Funding

Frontier Capital Invests $6.5 Million in M3TG

Aurora Funds Participates in $20 Million Investment in GA-based Pharma Company

Tengion Raises $33 Million in Third Round

Motricity to Acquire InfoSpace Mobile Services Division for $135 Million

October 8, 2007

Hamner Institutes Receives Diabetes Research Grant

NIST Awards HexaTech and Liquidia Each $2 Million for R&D Projects

RTI International Lands $3 Million Federal Contract

Salix Pharmaceuticals Licenses Rights to Market Treatment in France

Teleflex Medical Acquires Med Device Company

Hamner Institutes Receives Diabetes Research Grant

NIST Awards HexaTech and Liquidia Each $2 Million for R&D Projects

RTI International Lands $3 Million Federal Contract

Salix Pharmaceuticals Licenses Rights to Market Treatment in France

Teleflex Medical Acquires Med Device Company

October 1, 2007

PRA International Relocating to Raleigh

Hamner Institutes Awarded $450,000 Cancer Research Grant

Murdock Donates $35 Million to Duke University Medical School

Preation Acquires eWeb Designs

SJF Invests $1.5 Million in Organic Pizza Company

Overture Secures $12.3 Million in Series C Funding

Hatteras Investment Partners Raising $500 Million Fund

PRA International Relocating to Raleigh

Hamner Institutes Awarded $450,000 Cancer Research Grant

Murdock Donates $35 Million to Duke University Medical School

Preation Acquires eWeb Designs

SJF Invests $1.5 Million in Organic Pizza Company

Overture Secures $12.3 Million in Series C Funding

Hatteras Investment Partners Raising $500 Million Fund

September 24, 2007

Biogen Idec Partners with LigoCyte on Anti-inflammatory Drug Development

Xintek Partners with Siemens to Develop New X-ray Technologies

Trana Discovery develops tRNA HTS Assay Platform for Treatment of HIV

Network Appliance to Build Research Data Center

FDA Grants Approval to Alba Bioscience for Blood Grouping Reagents

Biomanufacturing Training and Education Center Opens on NCSU Centennial Campus

GlaxoSmithKline Awarded $41 Million Government Contract for Development of Antibiotics

RTP-based ChannelAdvisor Acquires Atlanta Firm

Aldagen Raises $9 Million More in Third Round

Echo Therapeutics Merges with Sontra Medical Corp.

Biogen Idec Partners with LigoCyte on Anti-inflammatory Drug Development

Xintek Partners with Siemens to Develop New X-ray Technologies

Trana Discovery develops tRNA HTS Assay Platform for Treatment of HIV

Network Appliance to Build Research Data Center

FDA Grants Approval to Alba Bioscience for Blood Grouping Reagents

Biomanufacturing Training and Education Center Opens on NCSU Centennial Campus

GlaxoSmithKline Awarded $41 Million Government Contract for Development of Antibiotics

RTP-based ChannelAdvisor Acquires Atlanta Firm

Aldagen Raises $9 Million More in Third Round

Echo Therapeutics Merges with Sontra Medical Corp.

September 17, 2007

SRC and NIST Partner to Develop Nanoelectronics Technology

GlaxoSmithKline Purchases Rights to Sell Sleep Drug

UNC Research Center Awarded $10 Million in Federal Funding

RTP-based ChannelAdvisor Acquires Atlanta Firm

Bioptigen Raises $500,000 in Angel Funding

Aldagen Raises $9 Million More in Third Round

SRC and NIST Partner to Develop Nanoelectronics Technology

GlaxoSmithKline Purchases Rights to Sell Sleep Drug

UNC Research Center Awarded $10 Million in Federal Funding

RTP-based ChannelAdvisor Acquires Atlanta Firm

Bioptigen Raises $500,000 in Angel Funding

Aldagen Raises $9 Million More in Third Round

September 9, 2007

NC General Assembly Funds $5 Million for Oxford Biofuels Center

Global Knowledge Acquires Synergy Professional Services

Icagen Begins Phase I Study for Treatment of Epilepsy

Pozen Signs Deal with AstraZeneca for $345 Million

BDSI Signs $60 Million License Agreement with Meda

ParagonDx Acquires Gentris Diagnostics, Inc.

NovaQuest Invests $25 Million in TOPIGEN Pharmaceuticals

NanoCor Raises $3.75 Million from Medtronic

Intersouth Invests in Massachusetts BioPharma Company

NC General Assembly Funds $5 Million for Oxford Biofuels Center

Global Knowledge Acquires Synergy Professional Services

Icagen Begins Phase I Study for Treatment of Epilepsy

Pozen Signs Deal with AstraZeneca for $345 Million

BDSI Signs $60 Million License Agreement with Meda

ParagonDx Acquires Gentris Diagnostics, Inc.

NovaQuest Invests $25 Million in TOPIGEN Pharmaceuticals

NanoCor Raises $3.75 Million from Medtronic

Intersouth Invests in Massachusetts BioPharma Company

September 4, 2007

Two Triangle Universities Ranked Among Nation’s Best for Entrepreneurship

Misys Healthcare and iMedica Team Up to Accelerate Healthcare IT Adoption

BioSignia Builds Strategic Partnership with Park Dansan

LipoScience, BioReference Laboratories Collaborate on Cardiovascular Testing

SPX Service Solutions to Acquire Matra-Werke GmbH

ParagonDx Acquires Gentris Diagnostics, Inc.

NovaQuest Invests $25 Million in TOPIGEN Pharmaceuticals

Eli Research Inc. Receives $10 Million in Investments from BIA Digital Partners

Two Triangle Universities Ranked Among Nation’s Best for Entrepreneurship

Misys Healthcare and iMedica Team Up to Accelerate Healthcare IT Adoption

BioSignia Builds Strategic Partnership with Park Dansan

LipoScience, BioReference Laboratories Collaborate on Cardiovascular Testing

SPX Service Solutions to Acquire Matra-Werke GmbH

ParagonDx Acquires Gentris Diagnostics, Inc.

NovaQuest Invests $25 Million in TOPIGEN Pharmaceuticals

Eli Research Inc. Receives $10 Million in Investments from BIA Digital Partners

August 27, 2007

NC IDEA Seeking Grant Applications

Nexus and UIC Form Strategic Alliance

Global Compliance and PrecisionIR Group Announce Strategic Partnership

Targacept Initiates Phase IIb Development of Schizophrenia Treatment

Icagen and Pfizer Join Forces in $1 Billion Deal

BioMarck Raises $4 Million in Private Investment

Epic Games Acquires Poland-based Game Developer

3Dsolve Acquired by Lockheed Martin

NC IDEA Seeking Grant Applications

Nexus and UIC Form Strategic Alliance

Global Compliance and PrecisionIR Group Announce Strategic Partnership

Targacept Initiates Phase IIb Development of Schizophrenia Treatment

Icagen and Pfizer Join Forces in $1 Billion Deal

BioMarck Raises $4 Million in Private Investment

Epic Games Acquires Poland-based Game Developer

3Dsolve Acquired by Lockheed Martin

August 20, 2007

NC IDEA Seeking Grant Applications

Inspire Releases New Eye Treatment Drug

UpSNAP to Merge with Mobile Greetings

TheraSim and INC Research Partner to Offer Management Solutions

NCHICA Releases New Security Template for Portable Device and Removable Media

UNC-CH Cancer Center Receives $50 Million Annual Funding

BioMarck Raises $4 Million in Private Investment

Biolex Files For $80 Million IPO

Parion Sciences Enters into $156 Million Deal with Gilead

Icagen and Pfizer Join Forces in $1 Billion Deal

NC IDEA Seeking Grant Applications

Inspire Releases New Eye Treatment Drug

UpSNAP to Merge with Mobile Greetings

TheraSim and INC Research Partner to Offer Management Solutions

NCHICA Releases New Security Template for Portable Device and Removable Media

UNC-CH Cancer Center Receives $50 Million Annual Funding

BioMarck Raises $4 Million in Private Investment

Biolex Files For $80 Million IPO

Parion Sciences Enters into $156 Million Deal with Gilead

Icagen and Pfizer Join Forces in $1 Billion Deal

August 13, 2007

Kennedy Covington Makes Pledge to Campaign for Cultural Facilities

rPath Receives Award for “Most Innovative Software Idea”

Lenovo Signs Deal to Acquire Packard Bell

NC Biotech Center Awards $822,000 in Grants to Scientists

Duke's Pratt Engineering School Launches Study for Ultrasound Cancer “Alarm”

Hatteras Venture Partners Raises Additional $20 Million for Third Fund

SRA Completes Acquisition of Constella Group

Kennedy Covington Makes Pledge to Campaign for Cultural Facilities

rPath Receives Award for “Most Innovative Software Idea”

Lenovo Signs Deal to Acquire Packard Bell

NC Biotech Center Awards $822,000 in Grants to Scientists

Duke's Pratt Engineering School Launches Study for Ultrasound Cancer “Alarm”

Hatteras Venture Partners Raises Additional $20 Million for Third Fund

SRA Completes Acquisition of Constella Group

August 6, 2007

Alphavax Releases Phase I Influenza Vaccine Clinical Trial Results

Constella Awards $200,000 to Four Family Health and Wellness Programs and Orphans with HIV/AIDS

Duke University Receives $14.5 Million Grant to Open Systems Biology Center

Virtual Heroes Enters into Agreement with Epic to Advance Serious Games

Zipit Wireless Receives $4.7 Million from Multiple Investors

TranS1 Files Statement for Proposed IPO

Hatteras Venture Partners Raises Additional $20 Million for Third Fund

Alphavax Releases Phase I Influenza Vaccine Clinical Trial Results

Constella Awards $200,000 to Four Family Health and Wellness Programs and Orphans with HIV/AIDS

Duke University Receives $14.5 Million Grant to Open Systems Biology Center

Virtual Heroes Enters into Agreement with Epic to Advance Serious Games

Zipit Wireless Receives $4.7 Million from Multiple Investors

TranS1 Files Statement for Proposed IPO

Hatteras Venture Partners Raises Additional $20 Million for Third Fund

July 30, 2007

Icagen Files IND for Potential Epilepsy Treatment

RTI Partners With Nine Companies to Take Part in USAID-Funded Program

Targacept Announces Initiation of Phase I Study of TC-5619

SRC Awarded the National Medal of Technology

Biolex Collects Positive Results from Hepatitis C Clinical Trial

Targacept Signs $1.5 Billion Deal with GlaxoSmithKline

TranS1 Files Statement for Proposed IPO

RadarFind Lands $3 Million in Series B Funding

Zipit Wireless Receives $4.7 Million from Multiple Investors

R.H. Donnelley Buys Business.com for $345 Million$345 million